Sutro Biopharma financial statements

수트로 바이오파머NASDAQ:STRO · Nasdaq · Healthcare · sector #17
$14.66+1.45%
2026-10-07 close · prelim

Sutro Biopharma's published financial data is dated 2026-10-04. 2024 revenue was $62M. 2024 operating profit was −$238M.

Reported results

Sutro Biopharma notifications

Quantus Signal · live data · not investment advice · Privacy Policy